EW vs SER · P/E 47, rev $1.39B vs rev $56.0K
Edwards Lifesciences Corp (EW) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SER currently screens at market cap $29.7M.
Not investment advice. Open the EW and SER stock pages for the full models.
Not investment advice.